These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 21291526)

  • 1. Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma.
    Jiang M; Liu Z; Xiang Y; Ma H; Liu S; Liu Y; Zheng D
    BMC Cancer; 2011 Feb; 11():54. PubMed ID: 21291526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway.
    Shamimi-Noori S; Yeow WS; Ziauddin MF; Xin H; Tran TL; Xie J; Loehfelm A; Patel P; Yang J; Schrump DS; Fang BL; Nguyen DM
    Cancer Gene Ther; 2008 Jun; 15(6):356-70. PubMed ID: 18309355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.
    Wang Y; He L; He G; Kong Y; Liu X; Cai H; Liu X; Tan W
    Sheng Wu Gong Cheng Xue Bao; 2010 Jun; 26(6):780-8. PubMed ID: 20815258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma.
    Kondo K; Yamasaki S; Sugie T; Teratani N; Kan T; Imamura M; Shimada Y
    Int J Cancer; 2006 Jan; 118(1):230-42. PubMed ID: 16003725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
    Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma.
    Kaliyaperumal K; Sharma AK; McDonald DG; Dhindsa JS; Yount C; Singh AK; Won JS; Singh I
    Redox Biol; 2015 Dec; 6():41-50. PubMed ID: 26177470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma.
    Adhim Z; Lin X; Huang W; Morishita N; Nakamura T; Yasui H; Otsuki N; Shigemura K; Fujisawa M; Nibu K; Shirakawa T
    Cancer Gene Ther; 2012 Feb; 19(2):144-52. PubMed ID: 22116375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adeno-associated virus-mediated doxycycline-regulatable TRAIL expression suppresses growth of human breast carcinoma in nude mice.
    Zheng L; Weilun Z; Minghong J; Yaxi Z; Shilian L; Yanxin L; Dexian Z
    BMC Cancer; 2012 Apr; 12():153. PubMed ID: 22530952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Licochalcone-A induces intrinsic and extrinsic apoptosis via ERK1/2 and p38 phosphorylation-mediated TRAIL expression in head and neck squamous carcinoma FaDu cells.
    Park MR; Kim SG; Cho IA; Oh D; Kang KR; Lee SY; Moon SM; Cho SS; Yoon G; Kim CS; Oh JS; You JS; Kim DK; Seo YS; Im HJ; Kim JS
    Food Chem Toxicol; 2015 Mar; 77():34-43. PubMed ID: 25572524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of combination therapy with adeno‑associated virus-delivered pigment epithelium-derived factor and cisplatin in a mouse model of Lewis lung carcinoma.
    He SS; Wu QJ; Gong CY; Luo ST; Zhang S; Li M; Lu L; Wei YQ; Yang L
    Mol Med Rep; 2014 Jun; 9(6):2069-76. PubMed ID: 24714917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer.
    Zhang X; Cheung RM; Komaki R; Fang B; Chang JY
    Clin Cancer Res; 2005 Sep; 11(18):6657-68. PubMed ID: 16166445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer.
    Li D; Day KV; Yu S; Shi G; Liu S; Guo M; Xu Y; Sreedharan S; O'Malley BW
    Cancer Res; 2002 Aug; 62(16):4637-44. PubMed ID: 12183420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditionally replicating adenovirus improves gene replication efficiency and anticancer effect of E1-deleted adenovirus carrying TRAIL in head and neck squamous cell carcinoma.
    Shim SH; Lee CT; Hun Hah J; Lee JJ; Park SW; Heo DS; Sung MW
    Cancer Sci; 2010 Feb; 101(2):482-7. PubMed ID: 19922505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death.
    Nguyen DM; Yeow WS; Ziauddin MF; Baras A; Tsai W; Reddy RM; Chua A; Cole GW; Schrump DS
    Cancer J; 2006; 12(4):257-73. PubMed ID: 16925970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective antitumor effects of the combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and cisplatin against esophageal squamous cell carcinoma.
    Kondo K; Yamasaki S; Inoue N; Sugie T; Teratani N; Kan T; Shimada Y
    Surg Today; 2006; 36(11):966-74. PubMed ID: 17072716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin.
    Chan LP; Chou TH; Ding HY; Chen PR; Chiang FY; Kuo PL; Liang CH
    Biochim Biophys Acta; 2012 Jul; 1820(7):1081-91. PubMed ID: 22554915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
    J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable SET knockdown in head and neck squamous cell carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro, as well as necrosis, cisplatin sensitivity and lymph node metastasis in xenograft tumor models.
    Sobral LM; Sousa LO; Coletta RD; Cabral H; Greene LJ; Tajara EH; Gutkind JS; Curti C; Leopoldino AM
    Mol Cancer; 2014 Feb; 13():32. PubMed ID: 24555657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide.
    Hingtgen S; Ren X; Terwilliger E; Classon M; Weissleder R; Shah K
    Mol Cancer Ther; 2008 Nov; 7(11):3575-85. PubMed ID: 19001440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.